Alimera Announces Submission of Marketing Authorization Application in Switzerland for ILUVIEN®
February 22, 2023 08:00 ET
|
Alimera Sciences, Inc.
ATLANTA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners...
Alimera Sciences Appoints Industry Veteran Russell L. Skibsted as Chief Financial Officer
January 09, 2023 08:00 ET
|
Alimera Sciences, Inc.
ATLANTA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners...